Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,746 | 3 | 78.4% |
| Food and Beverage | $2,885 | 150 | 15.3% |
| Travel and Lodging | $1,103 | 3 | 5.9% |
| Education | $65.20 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $14,133 | 13 | $0 (2024) |
| Genmab U.S., Inc. | $2,159 | 3 | $0 (2024) |
| PFIZER INC. | $395.03 | 36 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $363.87 | 13 | $0 (2024) |
| Celgene Corporation | $260.03 | 15 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $170.23 | 9 | $0 (2017) |
| Lilly USA, LLC | $153.05 | 12 | $0 (2018) |
| Straumann USA LLC | $126.85 | 6 | $0 (2020) |
| Eisai Inc. | $120.60 | 6 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $108.71 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,618 | 8 | Alexion Pharmaceuticals, Inc. ($5,290) |
| 2023 | $8,712 | 6 | Alexion Pharmaceuticals, Inc. ($8,712) |
| 2022 | $55.05 | 3 | Sirtex Medical Inc ($25.39) |
| 2020 | $126.85 | 6 | Straumann USA LLC ($126.85) |
| 2018 | $680.40 | 44 | PFIZER INC. ($195.33) |
| 2017 | $1,606 | 96 | PFIZER INC. ($199.70) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Consulting Fee | Cash or cash equivalent | $2,096.25 | General |
| Category: Oncology | ||||||
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $53.45 | General |
| Category: Oncology | ||||||
| 10/26/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Travel and Lodging | Cash or cash equivalent | $9.38 | General |
| Category: Oncology | ||||||
| 10/11/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: DESMOID TUMORS | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $110.81 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $5,290.00 | General |
| Category: Rare Disease | ||||||
| 01/08/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2023 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,360.00 | General |
| 08/11/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $59.94 | General |
| 08/11/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.83 | General |
| 08/10/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $595.02 | General |
| 08/10/2023 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $498.11 | General |
| 08/10/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $149.50 | General |
| 12/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Oncology | ||||||
| 08/24/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 06/07/2022 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: Interventional Oncology | ||||||
| 12/22/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| 11/23/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| 09/18/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| 08/26/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $36.71 | General |
| 07/23/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| 07/13/2020 | Straumann USA LLC | — | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| 10/16/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Endocrinology | ||||||
| 06/22/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,691 | 100,867 | $2.4M | $469,993 |
| 2022 | 41 | 1,626 | 116,423 | $4.0M | $756,303 |
| 2021 | 36 | 1,490 | 83,243 | $3.6M | $732,398 |
| 2020 | 36 | 1,216 | 68,482 | $2.2M | $315,617 |
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 15 | 7,000 | $955,000 | $301,391 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 684 | $251,712 | $61,891 | 24.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 71 | 232 | $164,024 | $21,907 | 13.4% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 49 | 43,350 | $216,750 | $17,112 | 7.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $63,845 | $13,304 | 20.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 271 | 998 | $35,928 | $7,590 | 21.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 78 | 144 | $45,072 | $6,714 | 14.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 95 | 438 | $28,032 | $4,527 | 16.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 29 | 90 | $30,960 | $4,314 | 13.9% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 35 | 111 | $15,873 | $3,888 | 24.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 46 | 157 | $24,649 | $3,359 | 13.6% |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 2023 | 15 | 21,600 | $43,200 | $3,353 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 53 | $13,250 | $3,164 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 357 | $7,140 | $2,999 | 42.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 50 | 229 | $24,732 | $2,626 | 10.6% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 25 | 115 | $18,515 | $2,412 | 13.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 153 | $14,688 | $1,529 | 10.4% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 22 | 56 | $14,336 | $1,332 | 9.3% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2023 | 14 | 12,906 | $103,248 | $1,305 | 1.3% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 27 | 9,150 | $45,750 | $1,026 | 2.2% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2023 | 17 | 425 | $127,500 | $839.34 | 0.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 22 | 95 | $3,230 | $602.30 | 18.6% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 17 | 34 | $3,876 | $594.89 | 15.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 15 | 84 | $36,204 | $553.89 | 1.5% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 32 | 680 | $77,520 | $497.77 | 0.6% |
About Dr. Andrew Jackson, MD
Dr. Andrew Jackson, MD is a Internal Medicine healthcare provider based in Shenandoah, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1760738355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Jackson, MD has received a total of $18,799 in payments from pharmaceutical and medical device companies, with $7,618 received in 2024. These payments were reported across 163 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($14,746).
As a Medicare-enrolled provider, Jackson has provided services to 6,023 Medicare beneficiaries, totaling 369,015 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Student in an Organized Health Care Education/Training Program
- Location Shenandoah, TX
- Active Since 08/01/2012
- Last Updated 10/04/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760738355
Products in Payments
- ULTOMIRIS (Biological) $5,290
- Epkinly (Drug) $2,159
- Abraxane (Drug) $145.43
- AFINITOR (Drug) $140.60
- SOLIRIS (Drug) $130.42
- OPDIVO (Biological) $114.70
- IBRANCE (Drug) $111.82
- SCEMBLIX (Drug) $110.81
- SUTENT (Drug) $99.41
- ERBITUX (Drug) $89.00
- CHANTIX (Drug) $86.30
- Lenvima (Drug) $78.96
- Neulasta (Biological) $71.27
- SPRYCEL (Drug) $68.75
- Xofigo (Drug) $62.76
- IMFINZI (Drug) $61.11
- Pomalyst (Drug) $59.56
- Revlimid (Drug) $55.04
- Somatuline Depot 120mg-.5ml (Drug) $49.69
- JAKAFI (Drug) $49.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shenandoah
George Manoukian, M.d, M.D
Internal Medicine — Payments: $252,502
Dr. Rajesh Venkataraman
Internal Medicine — Payments: $226,580
Paul Cunningham, M.d, M.D
Internal Medicine — Payments: $29,344
Dustin Agan, Md, MD
Internal Medicine — Payments: $28,308
Thimos Paschalis, M.d, M.D
Internal Medicine — Payments: $25,701
Christopher Nguyen, M.d, M.D
Internal Medicine — Payments: $13,238